...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** BETonMACE Trial is Fully Enrolled and Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155

Message: Roth Conference March 19th 11:00 AM Fireside Chat

Thanks Koo....looks like the pattern of 'little up, little down' continues, given the way the PPS is basically languishing I wasn't expecting much either way.  

New Message
Please login to post a reply